# The Elixir Bioadaptor vs. The Onyx Stent in De Novo Native Coronary Arteries

Study · id `cardio:ct-nct04192747` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04192747](<https://clinicaltrials.gov/study/NCT04192747>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04192747

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 445 participants.

## Technical summary

Registry record NCT04192747. Randomized; double masking; primary purpose treatment. Start 2020-12-16 (actual); primary completion 2023-02-28 (actual). Results posted on 2024-10-22.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 445 participants (enrolled count; ClinicalTrials.gov record NCT04192747, source copy `cardio:ctgov-nct04192747-2025-03-24`, retrieved 2026-10-26)
- Started: 2020-12-16 (actual) (ClinicalTrials.gov record NCT04192747, source copy `cardio:ctgov-nct04192747-2025-03-24`, retrieved 2026-10-26)
- Primary completion: 2023-02-28 (actual) (ClinicalTrials.gov record NCT04192747, source copy `cardio:ctgov-nct04192747-2025-03-24`, retrieved 2026-10-26)
- Completion: 2027-02-28 (anticipated) (ClinicalTrials.gov record NCT04192747, source copy `cardio:ctgov-nct04192747-2025-03-24`, retrieved 2026-10-26)
- Results first posted: 2024-10-22 (ClinicalTrials.gov record NCT04192747, source copy `cardio:ctgov-nct04192747-2025-03-24`, retrieved 2026-10-26)
- Countries: Belgium; Germany; Japan; New Zealand (ClinicalTrials.gov record NCT04192747, source copy `cardio:ctgov-nct04192747-2025-03-24`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04192747-2025-03-24`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Elixir Bioadaptor vs. The Onyx Stent in De Novo Native Coronary Arteries
- Acronym: BIOADAPTOR RCT
- Condition: Coronary Artery Disease
- Condition: Coronary Artery Stenosis
- Condition: Coronary Disease
- Condition: Coronary Stenosis
- Intervention (Device): Percutaneous Coronary Intervention
- Lead sponsor: Elixir Medical Corporation
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Elixir Medical Corporation (`cardio:org-elixir-medical-corporation`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Percutaneous Coronary Treatment With Bioadaptor Implant vs Drug-Eluting Stent: 2-Year Outcomes From BIOADAPTOR RCT (`cardio:pubmed-40057888`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 271993634da79808748e00abd87df4c6661ac487db765e1fcb46f10eaae09d4c
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
